<HTML>
<HEAD>
<TITLE>Wright Medical Group, Inc.</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt">As filed with the Securities and Exchange Commission on May&nbsp;14, 2004



<P align="right" style="font-size: 10pt">Registration No.&nbsp;333-_____


<P>
<HR noshade width="100%" align="center" size="4">




<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, D.C. 20549</B>
</DIV>

<P align="center" style="font-size: 18pt"><B>FORM S-8</B>


<P align="center" style="font-size: 10pt">REGISTRATION STATEMENT UNDER<BR>
THE SECURITIES ACT OF 1933


<P align="center" style="font-size: 24pt"><B>WRIGHT MEDICAL GROUP, INC.</B>


<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="75%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or other jurisdiction
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>13-4088127</B><BR>
(I.R.S. Employer</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top">of incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Identification No.)</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><B>5677 Airline Road</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><B>Arlington, Tennessee</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>38002</B></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top">(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><B>Wright Medical Group, Inc.<BR>
Third Amended and Restated 1999 Equity Incentive Plan</B><BR>
(Full title of the plan)




<HR noshade width="100%" align="center" size="1">




<DIV align="center" style="font-size: 10pt"><B>F. Barry Bays<BR>
President and Chief Executive Officer<BR>
Wright Medical Group, Inc.<BR>
5677 Airline Road<BR>
Arlington, Tennessee 38002</B><BR>
(Name and address of agent for service)
</DIV>



<HR noshade width="100%" align="center" size="1">




<DIV align="center" style="font-size: 10pt"><B>(901)&nbsp;867-9971</B><BR>
(Telephone number, including area code, of agent for service)
</DIV>



<HR noshade width="100%" align="center" size="1">




<DIV align="center" style="font-size: 10pt">Copy to:<BR>
Peter H. Kesser, Esq.<BR>
Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, P.C.<BR>
165 Madison Avenue, 20th Floor<BR>
Memphis, TN 38103<BR>
(901)&nbsp;526-2000
</DIV>



<HR noshade width="100%" align="center" size="1">




<DIV align="center" style="font-size: 10pt">CALCULATION OF REGISTRATION FEE
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="25%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Title of</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Maximum</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Maximum</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Securities to be</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount to be</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Offering Price</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Aggregate</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount of</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Registered</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Registered(1)</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Per Share Price(2)</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Offering(2)</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Registration Fee</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:10px; text-indent:-10px">Common Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,500,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">33.62</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">50,430,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">6,389.48</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>




<P>
<HR size="1" width="18%" align="left" noshade>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top">
    <TD width="1%" nowrap align="right">1.</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="96%">This registration statement covers 1,500,000 shares of Common
Stock, $.01 par value per share, of Wright Medical Group, Inc. (the
&#147;Common Stock&#148;) issuable pursuant to the Wright Medical Group, Inc.
Third Amended and Restated 1999 Equity Incentive Plan (the &#147;Plan&#148;). The
Plan authorizes the issuance of a maximum of 8,267,051 shares of Common
Stock, including the 1,500,000 shares being registered herein. In
addition, this registration statement covers such indeterminable number
of additional shares of Common Stock as may hereafter be offered or
issued pursuant to the Plan to prevent dilution resulting from stock
splits or similar transactions effected without receipt of
consideration and pursuant to Rule 416(c) under the Securities Act of
1933, as amended (the &#147;Securities Act&#148;).</TD>
</TR>

<TR><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD width="1%" nowrap align="right">2.</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="96%">Estimated solely for calculating the amount of the registration
fee. The registration fee has been calculated pursuant to paragraphs
(c)&nbsp;and (h)&nbsp;of Rule&nbsp;457 under the Securities Act based upon the average
of the high and low sales prices of the Common Stock as reported by the
Nasdaq National Market on May&nbsp;12, 2004.</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#001">INDEX TO EXHIBITS</A></TD></TR>
<TR><TD colspan="9"><A HREF="g89215exv4w1.txt">Ex-4.1 Fourth Amended and Restated Certificate</A></TD></TR>
<TR><TD colspan="9"><A HREF="g89215exv4w6.txt">Ex-4.6 Form of Executive Stock Option Agreement</A></TD></TR>
<TR><TD colspan="9"><A HREF="g89215exv5.txt">Ex-5  Opinion Baker,Donelson,Bearman,Caldwell,</A></TD></TR>
<TR><TD colspan="9"><A HREF="g89215exv23w1.txt">Ex-23.1 Consent of KPMG LLP</A></TD></TR>
<TR><TD colspan="9"><A HREF="g89215exv23w2.txt">Ex-23.2 Notice / consent of Arthur Anderen LLP</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>





<P align="center" style="font-size: 10pt"><B>STATEMENT UNDER GENERAL INSTRUCTION E -<BR>
REGISTRATION OF ADDITIONAL SECURITIES</B>


<P align="left" style="font-size: 10pt">The stockholders of Wright Medical Group, Inc. (the &#147;Company&#148;) originally
approved the Company&#146;s 1999 Equity Incentive Plan on December&nbsp;7, 1999, and the
plan was subsequently amended and restated on July&nbsp;6, 2001, and May&nbsp;13, 2003.
On May&nbsp;13, 2004, the Company&#146;s stockholders approved an amendment increasing
the number of shares of Common Stock available for awards thereunder by
1,500,000 shares, which are the subject of this registration statement.


<P align="left" style="font-size: 10pt">The contents of the Company&#146;s earlier registration statements related to the
Plan, File Number 333-75176 and File Number 333-108638, are incorporated herein
by reference.



<P align="center" style="font-size: 10pt"><B>PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>



<P align="left" style="font-size: 10pt"><B>Item&nbsp;3. Incorporation of Certain Documents by Reference.</B>


<P align="left" style="font-size: 10pt">The following documents filed with the Securities and Exchange Commission (the
&#147;Commission&#148;) by the Company are incorporated by reference into this
registration statement:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Annual report on Form 10-K for the year ended December&nbsp;31, 2003 filed
with the Commission on February&nbsp;20, 2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Current report on Form 8-K filed with the Commission on January&nbsp;26, 2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Current report on Form 8-K filed with the Commission on February&nbsp;12,
2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Current report on Form 8-K filed with the Commission on March&nbsp;31, 2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">5.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Definitive proxy statement filed with the Commission on April&nbsp;7, 2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">6.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Current report on Form 8-K filed with the Commission on April&nbsp;27, 2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">7.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Quarterly report on Form 10-Q for the quarter ended March&nbsp;31, 2004 filed
with the Commission on April&nbsp;29, 2004; and</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">8.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of the Common Stock set forth under the heading
&#147;Description of Capital Stock &#151; Common Stock&#148; in the Prospectus portion of
Amendment No.&nbsp;2 to the registration statement on Form S-1 (Registration
No.&nbsp;333-81618) filed with the Commission on February&nbsp;28, 2002.</TD>
</TR>

</TABLE>

<P align="left" style="font-size: 10pt">All documents subsequently filed by the Company with the Commission pursuant to
Sections&nbsp;13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as
amended, prior to the filing of a post-effective amendment which indicates that
all the securities offered hereby have been sold or which deregisters all
securities then remaining unsold, shall be deemed to be incorporated by
reference in this registration statement and to be a part hereof from the date
of the filing of such documents with the Commission.



<P align="left" style="font-size: 10pt"><B>Item&nbsp;8. Exhibits.</B>


<P align="left" style="font-size: 10pt">See Index to Exhibits following the signature page herein.



<P align="center" style="font-size: 10pt">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="000"></A></DIV>

<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>


<P align="left" style="font-size: 10pt">Pursuant to the requirements of the Securities Act of 1933, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Arlington, State of Tennessee, on May&nbsp;14, 2004.



<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top">&nbsp;</TD>
    <TD colspan="3">WRIGHT MEDICAL GROUP, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000">/s/ F. Barry Bays
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2">F. Barry Bays&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt"><B>POWER OF ATTORNEY</B>


<P align="left" style="font-size: 10pt">Each of the undersigned directors and officers of Wright Medical Group, Inc.
hereby severally constitutes and appoints Jason P. Hood and John K. Bakewell,
and each of them, as the attorneys-in-fact for the undersigned, in any and all
capacities, with full power of substitution, to sign any and all pre- or
post-effective amendments to this registration statement, any subsequent
registration statement for the same offering which may be filed pursuant to
Rule 462(b) under the Securities Act of 1933, as amended, and any and all pre-
or post-effective amendments thereto, and to file the same with exhibits
thereto and other documents in connection therewith, with the Securities and
Exchange Commission, granting unto said attorneys-in-fact full power and
authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and
purposes as he might or could do in person, hereby ratifying and confirming all
that said attorney-in-fact may lawfully do or cause to be done by virtue
hereof.


<P align="left" style="font-size: 10pt">Pursuant to the requirements of the Securities Act of 1933, as amended, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated:


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="39%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Signature</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Title</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Date</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" nowrap valign="top">/s/ F. BARRY BAYS<BR>
<HR size="1" noshade>
F. Barry Bays</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
President, Chief Executive<BR>
Officer and Director<BR>
(Principal Executive Officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 14, 2004</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ JOHN K. BAKEWELL<BR>
<HR size="1" noshade>
John K. Bakewell</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Executive Vice President and<BR>
Chief Financial Officer<BR>
(Principal Financial Officer<BR>
and Principal Accounting<BR>
Officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 14, 2004</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ JAMES T. TREACE<BR>
<HR size="1" noshade>
James T. Treace</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Chairman of the Board
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 14, 2004</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ RICHARD B. EMMITT<BR>
<HR size="1" noshade>
Richard B. Emmitt</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 14, 2004</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ LAURENCE Y. FAIREY<BR>
<HR size="1" noshade>
Laurence Y. Fairey</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 14, 2004</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ DAVID D. STEVENS<BR>
<HR size="1" noshade>
David D. Stevens</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 14, 2004</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ JAMES E. THOMAS<BR>
<HR size="1" noshade>
James E. Thomas</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 14, 2004</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ THOMAS E. TIMBIE<BR>
<HR size="1" noshade>
Thomas E. Timbie</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 14, 2004</TD>
</TR>

<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" nowrap valign="top">/s/ ELIZABETH H. WEATHERMAN<BR>
<HR size="1" noshade>
Elizabeth H. Weatherman</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">May 14, 2004</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "INDEX TO EXHIBITS" -->
<DIV align="left"><A NAME="001"></A></DIV>

<P align="center" style="font-size: 10pt"><B>INDEX TO EXHIBITS</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="85%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="6%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="91%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit No.</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Description of Exhibits</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fourth Amended and Restated Certificate of Incorporation of Wright Medical Group, Inc.,
<sup>(1)</sup>&nbsp;as amended by Certificate of Amendment of Fourth Amended and Restated Certificate
of Incorporation of Wright Medical Group, Inc.</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Bylaws of
Wright Medical Group, Inc. <sup>(2)</sup></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Third Amended and Restated 1999
Equity Incentive Plan (the &#147;1999 Plan&#148;). <sup>(3)</sup></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Incentive Stock Option Agreement, as amended by form of Amendment No.&nbsp;1 to
Incentive Stock Option Agreement, pursuant to the 1999 Plan. <sup>(1)</sup></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Non-Qualified Stock Option
Agreement pursuant to the 1999 Plan. <sup>(1)</sup></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.6
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Executive Stock Option Agreement pursuant to the 1999 Plan.</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.7
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Non-Employee Director Stock Option Agreement pursuant to the 1999 Plan. <sup>(1)</sup></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, P.C. concerning the legality
of the securities being registered.</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of KPMG LLP.</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notice regarding consent of Arthur Andersen LLP.</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Baker, Donelson, Bearman, Caldwell &#038; Berkowitz, P.C. (included in Exhibit&nbsp;5).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (reference is made to the signature page).</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>




<P>
<HR size="1" width="18%" align="left" noshade>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top">
    <TD width="1%" nowrap align="right">(1)</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="96%">Incorporated by reference to the Company&#146;s registration statement on Form
S-1 (Registration No.&nbsp;333-59732), as amended.</TD>
</TR>

<TR><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD width="1%" nowrap align="right">(2)</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="96%">Incorporated by reference to the Company&#146;s current report on Form 8-K
filed with the Commission on March&nbsp;31, 2004.</TD>
</TR>

<TR><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD width="1%" nowrap align="right">(3)</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="96%">Incorporated by reference to the Company&#146;s definitive proxy statement
filed with the Commission on April&nbsp;7, 2004.</TD>
</TR>

</TABLE>




<P align="center" style="font-size: 10pt">3
</DIV>


</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g89215sv8.htm", "description": "WRIGHT MEDICAL GROUP, INC.", "secsgml_size_bytes": 26536}]
{"company-data": {"conformed-name": "WRIGHT MEDICAL GROUP INC", "cik": "0001137861", "assigned-sic": "3842", "irs-number": "134088127", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-115541", "film-number": "04808769"}, "business-address": {"street1": "5677 AIRLINE ROAD", "city": "ARLINGTON", "state": "TN", "zip": "38002", "phone": "9018679971"}}
Wright Medical Group, Inc.
Table of Contents
As filed with the Securities and Exchange Commission on May 14, 2004
Registration No. 333-_____
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
WRIGHT MEDICAL GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction
13-4088127
(I.R.S. Employer
of incorporation or organization)
Identification No.)
5677 Airline Road
Arlington, Tennessee
38002
(Address of Principal Executive Offices)
(Zip Code)
Wright Medical Group, Inc.
Third Amended and Restated 1999 Equity Incentive Plan
(Full title of the plan)
F. Barry Bays
President and Chief Executive Officer
Wright Medical Group, Inc.
5677 Airline Road
Arlington, Tennessee 38002
(Name and address of agent for service)
(901) 867-9971
(Telephone number, including area code, of agent for service)
Copy to:
Peter H. Kesser, Esq.
Baker, Donelson, Bearman, Caldwell & Berkowitz, P.C.
165 Madison Avenue, 20th Floor
Memphis, TN 38103
(901) 526-2000
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Title of
Maximum
Maximum
Securities to be
Amount to be
Offering Price
Aggregate
Amount of
Registered
Registered(1)
Per Share Price(2)
Offering(2)
Registration Fee
Common Stock
1,500,000
$
33.62
$
50,430,000
$
6,389.48
1.
This registration statement covers 1,500,000 shares of Common
Stock, $.01 par value per share, of Wright Medical Group, Inc. (the
"Common Stock") issuable pursuant to the Wright Medical Group, Inc.
Third Amended and Restated 1999 Equity Incentive Plan (the "Plan"). The
Plan authorizes the issuance of a maximum of 8,267,051 shares of Common
Stock, including the 1,500,000 shares being registered herein. In
addition, this registration statement covers such indeterminable number
of additional shares of Common Stock as may hereafter be offered or
issued pursuant to the Plan to prevent dilution resulting from stock
splits or similar transactions effected without receipt of
consideration and pursuant to Rule 416(c) under the Securities Act of
1933, as amended (the "Securities Act").
2.
Estimated solely for calculating the amount of the registration
fee. The registration fee has been calculated pursuant to paragraphs
(c) and (h) of Rule 457 under the Securities Act based upon the average
of the high and low sales prices of the Common Stock as reported by the
Nasdaq National Market on May 12, 2004.
TABLE OF CONTENTS
SIGNATURES
INDEX TO EXHIBITS
Ex-4.1 Fourth Amended and Restated Certificate
Ex-4.6 Form of Executive Stock Option Agreement
Ex-5  Opinion Baker,Donelson,Bearman,Caldwell,
Ex-23.1 Consent of KPMG LLP
Ex-23.2 Notice / consent of Arthur Anderen LLP
Table of Contents
STATEMENT UNDER GENERAL INSTRUCTION E -
REGISTRATION OF ADDITIONAL SECURITIES
The stockholders of Wright Medical Group, Inc. (the "Company") originally
approved the Company's 1999 Equity Incentive Plan on December 7, 1999, and the
plan was subsequently amended and restated on July 6, 2001, and May 13, 2003.
On May 13, 2004, the Company's stockholders approved an amendment increasing
the number of shares of Common Stock available for awards thereunder by
1,500,000 shares, which are the subject of this registration statement.
The contents of the Company's earlier registration statements related to the
Plan, File Number 333-75176 and File Number 333-108638, are incorporated herein
by reference.
PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Certain Documents by Reference.
The following documents filed with the Securities and Exchange Commission (the
"Commission") by the Company are incorporated by reference into this
registration statement:
1.
Annual report on Form 10-K for the year ended December 31, 2003 filed
with the Commission on February 20, 2004;
2.
Current report on Form 8-K filed with the Commission on January 26, 2004;
3.
Current report on Form 8-K filed with the Commission on February 12,
2004;
4.
Current report on Form 8-K filed with the Commission on March 31, 2004;
5.
Definitive proxy statement filed with the Commission on April 7, 2004;
6.
Current report on Form 8-K filed with the Commission on April 27, 2004;
7.
Quarterly report on Form 10-Q for the quarter ended March 31, 2004 filed
with the Commission on April 29, 2004; and
8.
The description of the Common Stock set forth under the heading
"Description of Capital Stock — Common Stock" in the Prospectus portion of
Amendment No. 2 to the registration statement on Form S-1 (Registration
No. 333-81618) filed with the Commission on February 28, 2002.
All documents subsequently filed by the Company with the Commission pursuant to
Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as
amended, prior to the filing of a post-effective amendment which indicates that
all the securities offered hereby have been sold or which deregisters all
securities then remaining unsold, shall be deemed to be incorporated by
reference in this registration statement and to be a part hereof from the date
of the filing of such documents with the Commission.
Item 8. Exhibits.
See Index to Exhibits following the signature page herein.
1
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Company
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Arlington, State of Tennessee, on May 14, 2004.
WRIGHT MEDICAL GROUP, INC.
By:
/s/ F. Barry Bays
F. Barry Bays
President and Chief Executive Officer
POWER OF ATTORNEY
Each of the undersigned directors and officers of Wright Medical Group, Inc.
hereby severally constitutes and appoints Jason P. Hood and John K. Bakewell,
and each of them, as the attorneys-in-fact for the undersigned, in any and all
capacities, with full power of substitution, to sign any and all pre- or
post-effective amendments to this registration statement, any subsequent
registration statement for the same offering which may be filed pursuant to
Rule 462(b) under the Securities Act of 1933, as amended, and any and all pre-
or post-effective amendments thereto, and to file the same with exhibits
thereto and other documents in connection therewith, with the Securities and
Exchange Commission, granting unto said attorneys-in-fact full power and
authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and
purposes as he might or could do in person, hereby ratifying and confirming all
that said attorney-in-fact may lawfully do or cause to be done by virtue
hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated:
Signature
Title
Date
/s/ F. BARRY BAYS
F. Barry Bays
President, Chief Executive
Officer and Director
(Principal Executive Officer)
May 14, 2004
/s/ JOHN K. BAKEWELL
John K. Bakewell
Executive Vice President and
Chief Financial Officer
(Principal Financial Officer
and Principal Accounting
Officer)
May 14, 2004
/s/ JAMES T. TREACE
James T. Treace
Chairman of the Board
May 14, 2004
/s/ RICHARD B. EMMITT
Richard B. Emmitt
Director
May 14, 2004
/s/ LAURENCE Y. FAIREY
Laurence Y. Fairey
Director
May 14, 2004
/s/ DAVID D. STEVENS
David D. Stevens
Director
May 14, 2004
/s/ JAMES E. THOMAS
James E. Thomas
Director
May 14, 2004
/s/ THOMAS E. TIMBIE
Thomas E. Timbie
Director
May 14, 2004
/s/ ELIZABETH H. WEATHERMAN
Elizabeth H. Weatherman
Director
May 14, 2004
2
Table of Contents
INDEX TO EXHIBITS
Exhibit No.
Description of Exhibits
4.1
Fourth Amended and Restated Certificate of Incorporation of Wright Medical Group, Inc.,
(1)
as amended by Certificate of Amendment of Fourth Amended and Restated Certificate
of Incorporation of Wright Medical Group, Inc.
4.2
Amended and Restated Bylaws of
Wright Medical Group, Inc.
(2)
4.3
Third Amended and Restated 1999
Equity Incentive Plan (the "1999 Plan").
(3)
4.4
Form of Incentive Stock Option Agreement, as amended by form of Amendment No. 1 to
Incentive Stock Option Agreement, pursuant to the 1999 Plan.
(1)
4.5
Form of Non-Qualified Stock Option
Agreement pursuant to the 1999 Plan.
(1)
4.6
Form of Executive Stock Option Agreement pursuant to the 1999 Plan.
4.7
Form of Non-Employee Director Stock Option Agreement pursuant to the 1999 Plan.
(1)
5
Opinion of Baker, Donelson, Bearman, Caldwell & Berkowitz, P.C. concerning the legality
of the securities being registered.
23.1
Consent of KPMG LLP.
23.2
Notice regarding consent of Arthur Andersen LLP.
23.3
Consent of Baker, Donelson, Bearman, Caldwell & Berkowitz, P.C. (included in Exhibit 5).
24
Power of Attorney (reference is made to the signature page).
(1)
Incorporated by reference to the Company's registration statement on Form
S-1 (Registration No. 333-59732), as amended.
(2)
Incorporated by reference to the Company's current report on Form 8-K
filed with the Commission on March 31, 2004.
(3)
Incorporated by reference to the Company's definitive proxy statement
filed with the Commission on April 7, 2004.
3